The BARI2D Clinical Trial: What Have We Learned?
Einstein-Montefiore Department of Medicine Grand Rounds
Thursday, October 8, 2009
First Floor Lecture Hall, Forchheimer/Einstein
Cherkasky Auditorium, Moses/Montefiore
Joel Zonszein, MD
Professor of Clinical Medicine, Department of Medicine (Endocrinology)
Director of the Clinical Diabetes Center East Campus
V.S. Srinivas, MB, BS
Associate Professor of Clinical Medicine, Department of Medicine (Cardiology)
Program Director, Interventional Cardiology Fellowship Program
Dr. V.S. Srinivas' major research interests are in outcomes research and in the interplay between diabetes and cardiovascular disease. He manages an active clinical research unit that participates in several multi-center clinical trials investigating new devices and therapies in cardiovascular disease. Except for a brief period of training at Brown University in Interventional Cardiology, Dr. Srinivas completed his training in Internal Medicine and Cardiology at Montefiore under Sharon Silbiger and James Scheuer. He is a recent graduate of the Clinical Research Training Master of Science Program in the Einstein Institute for Clinical and Translational Research.
Dr. Joel Zonszein is a co-investigator in the Albert Einstein College of Medicine Diabetes Research and Training Center (DRTC), and collaborated in landmark NIH clinically trials such as the Diabetes Control and Complication Trial (DCCT), and the Diabetes Prevention Program (DPP). He is the principal investigator of the "Bypass Angioplasty Revascularization Investigation 2 Diabetes" (BARI2D) an ongoing NIH sponsored study to elucidate the best management of ischemic coronary heart disease in patients with type 2 diabetes. He has a special interest in understanding cardiovascular disease in individuals with diabetes and or the metabolic syndrome. He continues to collaborate in several projects for diabetes care delivery systems in underserved minority populations, and he participates as a faculty member in the Albert Einstein College of Medicine Hispanic Center of Excellence (HCOE). Dr. Zonzsein is a consultant for the National Hispanic Medical Association, and a co-investigator and Scientific Director of the Bronx Center to Reduce and Eliminate Ethnic and Racial Health Disparities (BxCREED), supported by the NIH. He has created and actively participated in many educational programs, and serves in several advisory boards, especially those related to improve medical care in ethnically diverse populations. In 1993 he was recruited to work full time to develop the Clinical Diabetes Center at Montefiore Medical Center. He is certified by the American Boards of "Internal Medicine", "Endocrinology and Metabolism", and "Nuclear Medicine". He has ample clinical experience particularly in the area of diabetes. Dr. Zonszein is a member of several clinical societies, has published broadly, lectures extensively, and is recipient of many honors and awards.
This grand rounds is hosted by the Division of Endocrinology.
After attending this activity, participants will be able to:
- Understand the impact of Type 2 Diabetes on Cardiovascular Disease
- Identify the Best Strategies for Management of Stable Coronary Disease in Type 2 Diabetes
- Learn the Implication of Aggressive Medical Therapy in Patients with Type 2 Diabetes
- Learn Best Revascularization Strategies in Patients with Type 2 Diabetes and Coronary Artery Disease.
Albert Einstein College of Medicine designates this educational activity for a maximum of 1 credit towards the AMA Physician’s Recognition Award. Each physician should claim only those credits that he/she actually spent in the educational activity.
Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.